Categories AlphaGraphs, Earnings, Finance, LATEST

FactSet slips after Q4 results miss estimates

FactSet (FDS) reported fourth quarter 2018 results which, despite seeing growth, missed market expectations sending the stock down 5% during premarket hours.

The company posted a 5.9% increase in total revenues to $345.9 million while organic revenues grew 5.3% to $347.1 million compared to the same period last year. The growth in revenues was driven mainly by higher sales of research and analytics products, content and technology solutions and wealth management solutions.

Net income grew 15.6% to $68.8 million and diluted EPS rose 16.4% to $1.77 versus the prior-year quarter. Adjusted diluted EPS improved 15.8% to $2.20, driven by the US Tax Cuts and Jobs Act.

FactSet fourth quarter 2018 earnings
FactSet Q4 2018 Earnings Infographic

Annual Subscription Value (ASV) increased to $1.39 billion compared to the prior-year. For the fourth quarter, the company recorded its highest-ever organic ASV growth of $38.6 million. Research ASV remained flat during the quarter at $637.2 million while ASVs in Analytics, Content and Technology Solutions and Wealth saw increases.

FactSet’s client count increased during the quarter driven mainly by institutional asset managers and wealth management while the user count saw improvements due to higher investment banking workstation sales.

For fiscal-year 2019, the company expects GAAP revenues to be $1.41 billion to $1.45 billion. GAAP diluted EPS is expected to be $8.70 to $8.90 while adjusted diluted EPS is expected to be $9.45 to $9.65. Organic ASV plus professional services is expected to grow by $75 million to $90 million over 2018.

FactSet added that it appointed Helen Shan as the new Chief Financial Officer in September.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top